Orion SPAC raises $200m for IPO
Orion Biotech Opportunities Corp, a blank check company that is backed by MSD Partners and Panacea, has raised $200 million for its IPO after pricing its 20 million shares at $10 per share.
Orion Biotech Opportunities Corp, a blank check company that is backed by MSD Partners and Panacea, has raised $200 million for its IPO after pricing its 20 million shares at $10 per share.
Copyright PEI Media
Not for publication, email or dissemination